Dapagliflozin modulates diabetic kidney disease through indirect transcriptional regulation rather than direct transcriptional reversal.

Pesce F, Strizzi CT, Granata A, Bracaccia ME, Muzi L, Liakopoulos V, Grandaliano G

Open source

DOI
10.1093/joneph/aajag074
Published
2026 Aug 28
Container
Journal of nephrology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/joneph/aajag074,
  title = {Dapagliflozin modulates diabetic kidney disease through indirect transcriptional regulation rather than direct transcriptional reversal.},
  author = {Pesce F and Strizzi CT and Granata A and Bracaccia ME and Muzi L and Liakopoulos V and Grandaliano G},
  year = {2026},
  journal = {Journal of nephrology},
  doi = {10.1093/joneph/aajag074},
  url = {https://doi.org/10.1093/joneph/aajag074}
}

RIS

TY  - JOUR
TI  - Dapagliflozin modulates diabetic kidney disease through indirect transcriptional regulation rather than direct transcriptional reversal.
AU  - Pesce F
AU  - Strizzi CT
AU  - Granata A
AU  - Bracaccia ME
AU  - Muzi L
AU  - Liakopoulos V
AU  - Grandaliano G
PY  - 2026
JO  - Journal of nephrology
DO  - 10.1093/joneph/aajag074
UR  - https://doi.org/10.1093/joneph/aajag074
ER  - 

APA

F, P., CT, S., A, G., ME, B., L, M., V, L., & G, G. (2026). Dapagliflozin modulates diabetic kidney disease through indirect transcriptional regulation rather than direct transcriptional reversal.. Journal of nephrology. https://doi.org/10.1093/joneph/aajag074

Source records